Newswire

HSV-1 Liquifies Cell Nuclei to Aid Replication

A study headed by researchers at NYU Langone Health has found that herpes simplex virus 1 (HSV-1) partially liquifies the tightly packed, gel-like interior of human cell nuclei to help copy itself faster. This discovery sheds light on the intricate mechanisms viruses employ to manipulate host cellular environments for their replication, particularly in the context of nuclear molecular crowding that typically hinders viral processes.

The research team, led by Liam Holt, PhD, along with Ian Mohr, PhD, and Angus Wilson, PhD, identified that the viral protein infected cell protein 4 (ICP4) plays a crucial role in this fluidization process. By altering the biophysical properties of the nucleus, ICP4 facilitates the formation of viral replication compartments, thereby enhancing the efficiency of HSV-1 replication. This finding not only underscores the adaptability of viruses but also suggests potential therapeutic targets that could disrupt these viral strategies.

As the researchers continue to explore the mechanisms by which ICP4 fluidizes the nucleus, they aim to determine whether similar strategies are employed by other viruses that replicate within the nucleus. The implications of this research extend beyond HSV-1, potentially informing the development of broad-spectrum antiviral therapies that could inhibit viral replication by stabilizing nuclear biophysical properties.

Explore deeper: the API & FDF Intelligence database is more than a directory. It combines global coverage of APIs, excipients, and finished dosage forms with real market intelligence. You’ll find: – Price ranges for APIs, excipients, and formulations. – DMF, CEP, and GMP compliance status. – Manufacturer portfolios by product and geography. – Direct contacts for every producer and FDF holder, ready for outreach. Instead of scattered spreadsheets and endless searches, the entire picture is a few clicks away. Subscription starts at an accessible rate — see how much time and budget you save by centralizing everything.
Start your 7-day trial and see what the database can do →